Kathryn Wekselman, PhD, RN has joined as Director, Regulatory and Scientific ... PharmaLive (press release) (subscription) CTI focuses on critically and chronically ill patient populations in the specific disease areas of solid organ transplant, hepatitis, infectious disease, hematology/oncology, stem cell transplant and regenerative medicine, and end-stage organ disease ... |
